NASDAQ:DBVT
DBV Technologies S.A. Stock News
$0.682
+0.0207 (+3.13%)
At Close: Apr 19, 2024
DBV Technologies annonce la nomination du nouveau Président de son Comité d’Audit et de Danièle Guyot-Caparros au Conseil d’Administration
08:30pm, Monday, 03'rd Oct 2022 GlobeNewswire Inc.
Montrouge, France, le 3 octobre (22 h 30 CEST) 2022
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
04:40pm, Wednesday, 28'th Sep 2022 Benzinga
Gainers
Prothena Corporation plc (NASDAQ: PRTA) shares climbed 76.4% to $54.54 after Biogen and Eisai Co. Ltd. announced late Tuesday positive results from a late-stage study of their Alzheimer’s
Algoma Steel Group, Sandstorm Gold And Some Other Big Stocks Moving Lower On Tuesday
03:54pm, Wednesday, 28'th Sep 2022 Benzinga
U.S. stocks traded higher, with the Dow Jones gaining around 300 points on Wednesday. Here are some big stocks recording losses in today’s session.
Grove Collaborative Holdings, Inc. (NYSE: GROV) d
DBV Technologies' (DBVT) Peanut Allergy Study on Partial Hold
02:57pm, Friday, 23'rd Sep 2022 Zacks Investment Research
DBV Technologies (DVBT) announces partial hold on phase III study of modified Viaskin Peanut 250 ??g patch, VITESSE, by the FDA. Stock declines.
DBV Technologies' (DBVT) Peanut Allergy Study on Partial Hold
12:02pm, Friday, 23'rd Sep 2022
DBV Technologies (DVBT) announces partial hold on phase III study of modified Viaskin Peanut 250 ??g patch, VITESSE, by the FDA.
Why Avenue Therapeutics Shares Surged Around 106%; Here Are 87 Biggest Movers From Yesterday
07:42am, Friday, 23'rd Sep 2022 Benzinga
Gainers
Spero Therapeutics, Inc. (NASDAQ: SPRO) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it has entered into an exclusive license agreement with GSK for Spero's
Why MediWound Is Trading Lower By Around 18%, Here Are 48 Stocks Moving In Thursday's Mid-Day Session
04:26pm, Thursday, 22'nd Sep 2022 Benzinga
Gainers
Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 150% to $2.0508 after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, t
DBV Technologies Provides Clinical Update on VITESSE Phase 3 Trial
09:45pm, Wednesday, 21'st Sep 2022 GlobeNewswire Inc.
Montrouge, France, September 21, 2022
DBV Technologies fait le point sur l’étude clinique de phase 3 VITESSE
09:45pm, Wednesday, 21'st Sep 2022 GlobeNewswire Inc.
Montrouge, France, le 21 septembre (23 h 45 CEST) 2022
Wayfair, American Eagle Outfitters And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
12:00pm, Thursday, 08'th Sep 2022 Benzinga
U.S. stock futures traded slightly higher this morning after recording gains in the previous session. Here are some big stocks moving lower in today’s pre-market trading session.
American Eagle Out
Why Asana Is Trading Higher By 24%; Here Are 24 Stocks Moving Premarket
11:27am, Thursday, 08'th Sep 2022 Benzinga
Gainers
Asana, Inc. (NYSE: ASAN) rose 24.1% to $23.62 in pre-market trading after the company reported better-than-expected results for its second quarter and issued a strong sales guidance.
AcelRx
DBV Technologies to Present at Upcoming Investor Conferences
04:30pm, Friday, 02'nd Sep 2022
Montrouge, France, September 2, 2022
Is DBV Technologies (DBVT) Stock Outpacing Its Medical Peers This Year?
11:19am, Tuesday, 23'rd Aug 2022
Here is how DBV Technologies S.A. (DBVT) and ProPhase Labs, Inc. (PRPH) have performed compared to their sector so far this year.
DBV Technologies: Good Data, Plenty Of Cash And Regulatory Uncertainty
07:38pm, Thursday, 07'th Jul 2022
DBV Technologies is a French company traded on Nasdaq which is developing treatments for food allergies. Their technology is a patch that delivers a very small daily dose of the allergen to desensitiz
2 Biotechs That Recently Soared -- Are They Buys?
10:23am, Thursday, 30'th Jun 2022
Let's consider the risk-reward profile of these companies before jumping on the bandwagon.
